abstract |
(57) Summary: (a) a thienopyridine derivative represented by the formula (I) wherein R is hydrogen or a C 1-4 alkoxycarbonyl group or a pharmaceutically acceptable salt thereof; and (b) Pharmaceutical compositions containing HMG-CoA-reductase inhibitors have been described. |